These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 20129431)

  • 21. Prevalence of chronic hepatitis C virus genotypes among patients between 21 to 65 years old in Puerto Rico.
    Rodríguez-Pérez F; Suárez-Pérez E; Alvarez-Rohena M; Toro DH
    P R Health Sci J; 2004 Jun; 23(2 Suppl):49-56. PubMed ID: 16929587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C virus genotypes in 1,504 patients in Slovenia, 1993-2007.
    Seme K; Vrhovac M; Mocilnik T; Maticic M; Lesnicar G; Baklan Z; Volkar JM; Rajter M; Stepec S; Lunar M; Poljak M
    J Med Virol; 2009 Apr; 81(4):634-9. PubMed ID: 19235845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistent hepatitis C viremia after acute self-limiting posttransfusion hepatitis C.
    Barrera JM; Bruguera M; Ercilla MG; Gil C; Celis R; Gil MP; del Valle Onorato M; Rodés J; Ordinas A
    Hepatology; 1995 Mar; 21(3):639-44. PubMed ID: 7533121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C virus RNA in peripheral blood mononuclear cells: comparing acute and chronic hepatitis C virus infection.
    Chang TT; Young KC; Yang YJ; Lei HY; Wu HL
    Hepatology; 1996 May; 23(5):977-81. PubMed ID: 8621178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural history of hepatitis C.
    Seeff LB
    Hepatology; 1997 Sep; 26(3 Suppl 1):21S-28S. PubMed ID: 9305659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Compensation of victims of nosocomial or post-transfusion hepatitis C virus infection].
    Manaouil C; Capron D; Nguyen-Khac E; Jardé O
    Gastroenterol Clin Biol; 2007 Feb; 31(2):185-94. PubMed ID: 17347629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood and bioidentity: ideas about self, boundaries and risk among blood donors and people living with hepatitis C.
    Waldby C; Rosengarten M; Treloar C; Fraser S
    Soc Sci Med; 2004 Oct; 59(7):1461-71. PubMed ID: 15246174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
    Chen DS
    Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prevalence of chronic viral hepatitis in drug abusers].
    Osztrogonácz H; Gerevich J; Horváth G; Tolvaj G; Dávid K
    Orv Hetil; 2000 Apr; 141(14):715-8. PubMed ID: 10803013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The course of hepatitis C virus infection in pretransplantation anti-hepatitis C virus-negative renal transplant recipients: a retrospective follow-up study.
    Delladetsima I; Psichogiou M; Sypsa V; Psimenou E; Kostakis A; Hatzakis A; Boletis JN
    Am J Kidney Dis; 2006 Feb; 47(2):309-16. PubMed ID: 16431260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The risk of transfusion-acquired hepatitis-C virus infection among blood donors in Port Harcourt: the question of blood safety in Nigeria.
    Erhabor O; Ejele OA; Nwauche CA
    Niger J Clin Pract; 2006 Jun; 9(1):18-21. PubMed ID: 16986284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrahepatic cytokine profiles associated with posttransplantation hepatitis C virus-related liver injury.
    Zekry A; Bishop GA; Bowen DG; Gleeson MM; Guney S; Painter DM; McCaughan GW
    Liver Transpl; 2002 Mar; 8(3):292-301. PubMed ID: 11910576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of long-term outcomes of community-acquired hepatitis C infection in a cohort with sera stored from 1971 to 1975.
    Rodger AJ; Roberts S; Lanigan A; Bowden S; Brown T; Crofts N
    Hepatology; 2000 Sep; 32(3):582-7. PubMed ID: 10960453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serologic, virologic, and histologic characteristics of chronic phase hepatitis C virus disease in children infected by transfusion.
    Matsuoka S; Tatara K; Hayabuchi Y; Taguchi Y; Mori K; Honda H; Itou S; Yuasa Y; Kuroda Y
    Pediatrics; 1994 Dec; 94(6 Pt 1):919-22. PubMed ID: 7971011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three men infected with hepatitis C through contaminated blood start legal proceedings against UK government.
    Dyer C
    BMJ; 2015 Jan; 350():h302. PubMed ID: 25599967
    [No Abstract]   [Full Text] [Related]  

  • 36. Australian Senate committee decides against compensation for victims of infected blood.
    Burton B
    BMJ; 2004 Jun; 328(7455):1518. PubMed ID: 15217861
    [No Abstract]   [Full Text] [Related]  

  • 37. [Biodiversity and civil liability: the role of assessment].
    Boutonnet M
    J Int Bioethique; 2014 Mar; 25(1):45-54, 145. PubMed ID: 25073326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Forensic problems in blood transfusion].
    Boltz W
    Infusionsther Klin Ernahr; 1977 Apr; 4(2):96-8. PubMed ID: 558166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Canadians sue over hepatitis C infection.
    Spurgeon D
    BMJ; 1997 Aug; 315(7104):330. PubMed ID: 9270451
    [No Abstract]   [Full Text] [Related]  

  • 40. Case law update: a review of recent rulings of interest to risk managers. Jones v HealthSouth Treasure Valley Hospital, 206 P.3d 473 (Idaho 2009).
    West JC
    J Healthc Risk Manag; 2010; 29(3):43-4. PubMed ID: 20301833
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.